<DOC>
	<DOC>NCT03057691</DOC>
	<brief_summary>The purpose of this study is to evaluate how major depressive disorder or generalized anxiety disorder could effect the prognosis of the patients post-ACS after PCI and whether the treatment or improvement of depression and anxiety could improve their prognosis.</brief_summary>
	<brief_title>The Impact of Depression and/or Anxiety on PCI Patients</brief_title>
	<detailed_description>This randomized, multicentric, prospective real-world clinical study is going to assess if post-PCI major depressive disorder or generalized anxiety disorder could deteriorate major adverse cardiovascular events and all-cause mortality in patients suffered from acute coronary syndrome, also whether treatment of depression and anxiety or the improvement of their depression and anxiety could improve their major adverse cardiovascular events and all-cause mortality. Meanwhile, this study will also assess if post-PCI major depressive disorder or generalized anxiety disorder could impact the high sensitivity C-reaction protein, blood lipid, blood glucose, blood pressure and cardiac function to explore the potential mechanism.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>aged &gt; 24 years old patients with a diagnosis of ACS (STelevation MI, nonSTelevation MI or unstable angina) and have undergone PCI have a good recovery from PCI within 12 months after PCI without any history of depression or anxiety volunteer for the study and sign the informed consent patients with other serious heart disease like heart failure with other severe mental illness like schizophrenia, dementia bipolar disorder taking antipsychotic drugs during the onset of ACS have taken monoamine oxidase inhibitors 14 days before recruitment have a serious risk of suicide poor social support contraindications for antidepressants or antianxiety drugs angleclosure glaucoma moderate or severe liver damage hyponatremia high risk of fracture torsades de pointes ventricular tachycardia or QTc prolongation pregnancy and lactation</criteria>
	<gender>All</gender>
	<minimum_age>24 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Generalized Anxiety Disorder</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
	<keyword>Major Adverse Cardiovascular Events</keyword>
</DOC>